Arrinex

Arrinex, Inc., headquartered in Silicon Valley, is dedicated to pioneering game-changing technologies to improve patients' quality of life. Collaborating with key opinion leaders, Arrinex developed the ClariFix Cryotherapy Device, a breakthrough solution for patients suffering from chronic rhinitis. The ClariFix Cryotherapy Device offers ENT specialists a minimally invasive method to interrupt the nerve pathways that trigger rhinitis symptoms. Treatment with the ClariFix device provides patients with a safe, effective, and long-lasting solution. The ClariFix device is the first and only FDA-approved medical device in the United States for treating adult chronic rhinitis.